Abstract
Purpose To assess the prevalence of vascular risk factors and thrombophilias in central and branch retinal artery occlusion in patients in whom an embolic source is not apparent.
Methods The study group consisted of 21 consecutive patients with retinal artery occlusion (RAO) in whom Doppler ultrasonography of the carotid arteries and transthoracic or transoesophageal echocardiography were normal. Laboratory methods included polymerase chain reaction for detection of factor V G1691A, factor II G20210A and methylentetrahydrofolate reductase C677T mutations, assays of plasma levels of protein C, free protein S, antithrombin, fibrinogen and homocysteine; and tests for the presence of lupus anticoagulant and anticardiolipin antibodies. Controls for the laboratory tests were 243 healthy subjects.
Results Nine of the 21 (43%) patients had at least one thrombophilic marker: 4 were homozygous for MTHFR C677T, 1 was heterozygous for factor V G1691A, 1 had a high titre of IgM anticardiolipin, 2 were heterozygous for factor V G1691A and homozygous for MTHFR C677T, and 1 had lupus anticoagulant, a high titre of IgM anticardiolipin, homozygosity for MTHFR C677T and hyperhomocysteinaemia. An interaction between vascular risk factors and thrombophilias seemed important since out of 14 patients with hypertension, diabetes and/or hypercholesterolaemia 7 (50%) had a thrombophilia. Homozygous MTHFR C677T was a significant risk factor with odds ratio of 3.18 (95% CI 1.20-8.47). The prevalence of factor V G1691A was also higher in the RAO patients versus controls with an odds ratio of 2.36 (95% CI 0.63-8.88), but this value did not reach significance, probably due to the small sample size.
Conclusion A search for thrombophilia in RAO is advisable in patients without evident source of emboli even when vascular risk factors are identified.
Similar content being viewed by others
Article PDF
References
Sharma S . The systemic evaluation of acute retinal artery occlusion. Curr Opin Ophthalmol 1998;9:1–5.
Ros MA, Magargal LE, Uram M . Branch retinal-artery obstruction: a review of 201 eyes. Ann Ophthalmol 1989;21:103–7.
Lip PL, Blann AD, Jones AF, Lip GYH . Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye 1998;12:245–51.
Wenzler EM, Rademakers AJ, Boers GH, et al. Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 1993;115:162–7.
Cahill M, Karabatzaki M, Meleady R, et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol 2000;84:154–7.
Greven CM, Slusher MM, Weaver RG . Retinal arterial occlusion in young adults. Am J Ophthalmol 1995;120:776–83.
Cobo-Soriano R, Sanchez-Ramon S, Aparicio MJ, et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 1999;128:725–32.
Vine AK, Samama MM . The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 1993;37:283–92.
Tayyanipour R, Pulido JS, Postel EA, et al. Arterial vascular occlusion associated with factor V Leiden gene mutation. Retina 1998;18:376–7.
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 1994;40:873–81.
Clauss A . Gerinnungsphysiologische schnell Methode zur Bestimmung des Fibrinogens. Acta Hematol 1957;17:237.
Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64–7.
Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111–3.
Zivelin A, Rosenberg N, Faier S, et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998;92:1119–24.
Martin SC, Rauz S, Marr JE, Martin N, Jones AF, Dodson FM Plasma total homocysteine and retinal vascular disease. Eye 2000;14:590–3.
Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7–9.
Talmon T, Scharf J, Mayer E, et al. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylenetetrahydrofolate reductase mutations. Am J Ophthalmol 1997;124:689–91.
Dhar-Munshi S, Ayliffe WH, Jayne D . Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor. Arch Ophthalmol 1999;117:971–3.
Greiner K, Hafnèr G, Prellwitz W, et al. Hereditare Storungen des Protein-C Systems bei Zentralarterien und Arteriolenastverschlussen. Klin Monatsbl Augenheilkd 1999;215:33–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salomon, O., Huna-Baron, R., Moisseiev, J. et al. Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source. Eye 15, 511–514 (2001). https://doi.org/10.1038/eye.2001.164
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.2001.164
Keywords
This article is cited by
-
Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Journal of Thrombosis and Thrombolysis (2016)
-
Recurrent branch retinal vein occlusion with factor V leiden mutation
Eye (2006)
-
Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion
Eye (2003)